Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

CORO7 Knockout Raji Polyclonal Cells

CORO7 Knockout Raji Polyclonal Cells is a knockout polyclonal cell population. The CORO7 was knocked out in the Raji cells using the CRISPR RNP technique.
Cat. No. ARG0881

OTUD7B Knockout Raji Polyclonal Cells

OTUD7B Knockout Raji Polyclonal Cells is a knockout polyclonal cell population. The OTUD7B was knocked out in the Raji cells using the CRISPR RNP technique.
Cat. No. ARG0880

FSBP Knockout Raji Polyclonal Cells

The FSBP Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from Raji B lymphocytes, designed for loss-of-function studies of the FSBP…
Cat. No. ARG0879

NUDT3 Knockout Raji Polyclonal Cells

NUDT3 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited B lymphocyte population with targeted disruption of the NUDT3 gene, which encodes a diphosphoinositol polyphosphate phosphohydrolase. This…
Cat. No. ARG0878

MYO19 Knockout Raji Polyclonal Cells

MYO19 Knockout Raji Polyclonal Cells provide a loss-of-function model system for studying mitochondrial dynamics and actin-based organelle transport in a B lymphocyte background. MYO19 is…
Cat. No. ARG0877

ZNF587B Knockout A2780 Cell Line

The ZNF587B Knockout A2780 Cell Line is a CRISPR/Cas9-edited cell line derived from the human ovarian carcinoma A2780 background. This model enables functional dissection of…
Cat. No. ARG44231

Zbp1 Knockout H9c2(2-1) Cell Line

The Zbp1 Knockout H9c2(2-1) Cell Line is a CRISPR/Cas9-edited knockout cell line derived from rat H9c2(2-1) cardiomyoblasts, featuring disruption of the cytosolic nucleic acid sensor…
Cat. No. ARG44230

Zbed6 Knockout C2C12 Cell Line

The Zbed6 Knockout C2C12 Cell Line is a CRISPR/Cas9-edited myoblast knockout line with disruption of the Zbed6 transcriptional repressor of Igf2. In C2C12 myoblasts, Zbed6…
Cat. No. ARG44229

Zbed6 Knockout AML12 Cell Line

The Zbed6 Knockout AML12 Cell Line is a CRISPR/Cas9-edited knockout model targeting the Zbed6 gene, a transcriptional repressor of insulin-like growth factor 2 (Igf2). Derived…
Cat. No. ARG44228

Ythdf2 Knockout Neuro-2a Cell Line

The Ythdf2 Knockout Neuro-2a Cell Line is a CRISPR/Cas9-edited loss-of-function model derived from mouse neuroblastoma. This cell line enables constitutive disruption of YTHDF2, the m6A…
Cat. No. ARG44227

YTHDF1 Knockout KYSE-140 Cell Line

The YTHDF1 Knockout KYSE-140 Cell Line is a CRISPR/Cas9-edited loss-of-function model in human esophageal squamous cell carcinoma. It enables targeted disruption of the m6A reader…
Cat. No. ARG44226

YTHDF1 Knockout IPEC-J2 Cell Line

The YTHDF1 Knockout IPEC-J2 Cell Line is a CRISPR/Cas9?edited knockout cell line derived from porcine jejunal epithelial cells. It provides a targeted loss?of?function model for…
Cat. No. ARG44225

Loading products...